Genomic profiling is now available for risk stratification of cytologically indeterminate thyroid nodules (ITNs). Mutations in
No takes yet. Share an insight, caveat, or question.
Sfreddo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: